Comprehensive Stock Comparison

Compare Addus HomeCare Corporation (ADUS) vs Enhabit, Inc. (EHAB) Stock

Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Try these comparisons:

Quick Verdict

CategoryWinnerWhy
GrowthADUS23.2% revenue growth vs EHAB's -1.1%
ValueADUSLower P/E (15.0x vs 22.5x)
Quality / MarginsADUS6.7% net margin vs EHAB's -1.1%
Stability / SafetyADUSBeta 0.41 vs EHAB's 0.56, lower leverage
DividendsTieNeither pays a meaningful dividend
Momentum (1Y)EHAB+62.6% vs ADUS's +8.1%
Efficiency (ROA)ADUS6.7% ROA vs EHAB's -1.0%, ROIC 8.8% vs -7.3%
Bottom line: ADUS leads in 5 of 7 categories, making it the stronger pick for investors who prioritize growth and revenue expansion and valuation and capital efficiency. Enhabit, Inc. is the better choice for recent price momentum and sentiment. As direct sector peers, they can serve as alternatives in the same portfolio allocation.

Who Each Stock Is For

Income & stability

Growth exposure

Long-term compounding (10Y)

Sleep-well-at-night portfolio

Defensive / Recession hedge

Business Model

What each company does and how it makes money

ADUSAddus HomeCare Corporation
Healthcare

Addus HomeCare is a provider of in-home care services for elderly, chronically ill, and disabled individuals across the United States. It generates revenue primarily through government reimbursement programs — with Medicaid accounting for roughly 80% of revenue — supplemented by Medicare, private insurance, and private-pay clients across its personal care, hospice, and home health segments. The company's competitive advantage lies in its established relationships with state Medicaid agencies and its scale as one of the largest home care providers, which creates barriers to entry and operational efficiencies.

EHABEnhabit, Inc.
Healthcare

Enhabit operates a network of home health and hospice care agencies across the United States, providing skilled nursing, therapy services, and end-of-life care to patients in their homes. The company generates revenue primarily from Medicare reimbursements — which account for the vast majority of its income — along with payments from Medicaid, private insurers, and patients. Its competitive advantage lies in its extensive geographic footprint across 34 states, which creates referral network effects and operational scale in a fragmented industry.

Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ADUSAddus HomeCare Corporation
FY 2025
Personal Care
76.6%$1.1B
Hospice
18.5%$263M
Home Health
5.0%$71M
EHABEnhabit, Inc.
FY 2024
Home Health Segment
100.0%$825M

Financial Metrics Comparison

Side-by-side fundamentals across 2 stocks. BestLagging

Financial Scorecard

ADUS 4EHAB 1
Financial MetricsADUS4/6 metrics
Valuation MetricsEHAB3/4 metrics
Profitability & EfficiencyADUS9/9 metrics
Total ReturnsADUS4/6 metrics
Risk & VolatilityTie1/2 metrics
Analyst OutlookADUS1/1 metrics

ADUS leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). EHAB leads in 1 (Valuation Metrics). 1 tied.

Financial Metrics (TTM)

ADUS and EHAB operate at a comparable scale, with $1.4B and $1.0B in trailing revenue. ADUS is the more profitable business, keeping 6.7% of every revenue dollar as net income compared to EHAB's -1.1%. On growth, ADUS holds the edge at +25.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricADUSAddus HomeCare Co…EHABEnhabit, Inc.
RevenueTrailing 12 months$1.4B$1.0B
EBITDAEarnings before interest/tax$155M$34M
Net IncomeAfter-tax profit$96M-$12M
Free Cash FlowCash after capex$91M$58M
Gross MarginGross profit ÷ Revenue+32.5%+48.4%
Operating MarginEBIT ÷ Revenue+9.7%+0.8%
Net MarginNet income ÷ Revenue+6.7%-1.1%
FCF MarginFCF ÷ Revenue+6.4%+5.5%
Rev. Growth (YoY)Latest quarter vs prior year+25.6%+3.9%
EPS Growth (YoY)Latest quarter vs prior year+50.5%+110.0%
ADUS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

MetricADUSAddus HomeCare Co…EHABEnhabit, Inc.
Market CapShares × price$1.9B$686M
Enterprise ValueMkt cap + debt − cash$2.0B$1.2B
Trailing P/EPrice ÷ TTM EPS19.87x-4.38x
Forward P/EPrice ÷ next-FY EPS est.15.01x22.50x
PEG RatioP/E ÷ EPS growth rate0.99x
EV / EBITDAEnterprise value multiple13.19x
Price / SalesMarket cap ÷ Revenue1.35x0.66x
Price / BookPrice ÷ Book value/share1.76x1.23x
Price / FCFMarket cap ÷ FCF14.47x
EHAB leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

ADUS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-2 for EHAB. ADUS carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to EHAB's 1.03x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs EHAB's 4/9, reflecting strong financial health.

MetricADUSAddus HomeCare Co…EHABEnhabit, Inc.
ROE (TTM)Return on equity+8.8%-2.0%
ROA (TTM)Return on assets+6.7%-1.0%
ROICReturn on invested capital+8.8%-7.3%
ROCEReturn on capital employed+10.9%-9.6%
Piotroski ScoreFundamental quality 0–974
Debt / EquityFinancial leverage0.19x1.03x
Net DebtTotal debt minus cash$127M$541M
Cash & Equiv.Liquid assets$82M$28M
Total DebtShort + long-term debt$209M$570M
Interest CoverageEBIT ÷ Interest expense11.40x0.93x
ADUS leads this category, winning 9 of 9 comparable metrics.

Total Returns (with DRIP)

A $10,000 investment in ADUS five years ago would be worth $10,104 today (with dividends reinvested), compared to $5,444 for EHAB. Over the past 12 months, EHAB leads with a +62.6% total return vs ADUS's +8.1%. The 3-year compound annual growth rate (CAGR) favors ADUS at -1.6% vs EHAB's -3.9% — a key indicator of consistent wealth creation.

MetricADUSAddus HomeCare Co…EHABEnhabit, Inc.
YTD ReturnYear-to-date-2.9%+49.7%
1-Year ReturnPast 12 months+8.1%+62.6%
3-Year ReturnCumulative with dividends-4.7%-11.3%
5-Year ReturnCumulative with dividends+1.0%-45.6%
10-Year ReturnCumulative with dividends+356.1%-45.6%
CAGR (3Y)Annualised 3-year return-1.6%-3.9%
ADUS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

ADUS is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than EHAB's 0.56 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EHAB currently trades 99.8% from its 52-week high vs ADUS's 83.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricADUSAddus HomeCare Co…EHABEnhabit, Inc.
Beta (5Y)Sensitivity to S&P 5000.41x0.56x
52-Week HighHighest price in past year$124.44$13.64
52-Week LowLowest price in past year$88.96$6.47
% of 52W HighCurrent price vs 52-week peak+83.2%+99.8%
RSI (14)Momentum oscillator 0–10041.084.1
Avg Volume (50D)Average daily shares traded173K419K
Evenly matched — ADUS and EHAB each lead in 1 of 2 comparable metrics.

Analyst Outlook

Wall Street rates ADUS as "Buy" and EHAB as "Hold". Consensus price targets imply 28.2% upside for ADUS (target: $133) vs -0.6% for EHAB (target: $14).

MetricADUSAddus HomeCare Co…EHABEnhabit, Inc.
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$132.75$13.53
# AnalystsCovering analysts1511
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises20
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
ADUS leads this category, winning 1 of 1 comparable metric.

Historical Charts

Charts are rendered on first load. Hover for details.

Chart 1Total Return — 5 Years (Rebased to 100)

StockJul 22Feb 26Change
Addus HomeCare Corp… (ADUS)100124.46+24.5%
Enhabit, Inc. (EHAB)90.9643.08-52.6%

Addus HomeCare Corp… (ADUS) returned +1% over 5 years vs Enhabit, Inc. (EHAB)'s -46%. A $10,000 investment in ADUS 5 years ago would be worth $10,104 today (including dividends reinvested).

Chart 2Revenue Growth — 10 Years

Stock20162025Change
Addus HomeCare Corp… (ADUS)$401M$1.4B+255.0%
Enhabit, Inc. (EHAB)$1.1B$1.0B-4.0%

Addus HomeCare Corporation's revenue grew from $401M (2016) to $1.4B (2025) — a 15.1% CAGR.

Chart 3Net Margin Trend — 10 Years

Stock20162025Change
Addus HomeCare Corp… (ADUS)3.0%6.7%+124.7%
Enhabit, Inc. (EHAB)7.0%-15.1%-317.0%

Addus HomeCare Corporation's net margin went from 3% (2016) to 7% (2025).

Chart 4P/E Ratio History — 9 Years

Stock20172025Change
Addus HomeCare Corp… (ADUS)29.720.6-30.6%

Addus HomeCare Corporation has traded in a 21x–56x P/E range over 9 years; current trailing P/E is ~20x.

Chart 5EPS Growth — 10 Years

Stock20162025Change
Addus HomeCare Corp… (ADUS)1.045.21+401.0%
Enhabit, Inc. (EHAB)19.23-3.11-116.2%

Addus HomeCare Corporation's EPS grew from $1.04 (2016) to $5.21 (2025) — a 20% CAGR.

Chart 6Free Cash Flow — 5 Years

2021
$35M
$119M
2022
$97M
$73M
2023
$103M
$45M
2024
$110M
$47M
2025
$0M
Addus HomeCare Corp… (ADUS)Enhabit, Inc. (EHAB)

Addus HomeCare Corporation generated $0M FCF in 2025 (-100% vs 2021). Enhabit, Inc. generated $47M FCF in 2024 (-60% vs 2021).

Loading custom metrics...

ADUS vs EHAB: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is ADUS or EHAB a better buy right now?

Addus HomeCare Corporation (ADUS) offers the better valuation at 19.9x trailing P/E (15.0x forward), making it the more compelling value choice. Analysts rate Addus HomeCare Corporation (ADUS) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ADUS or EHAB?

On forward P/E, Addus HomeCare Corporation is actually cheaper at 15.0x.

03

Which is the better long-term investment — ADUS or EHAB?

Over the past 5 years, Addus HomeCare Corporation (ADUS) delivered a total return of +1.0%, compared to -45.6% for Enhabit, Inc. (EHAB). A $10,000 investment in ADUS five years ago would be worth approximately $10K today (assuming dividends reinvested). Over 10 years, the gap is even starker: ADUS returned +356.1% versus EHAB's -45.6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ADUS or EHAB?

By beta (market sensitivity over 5 years), Addus HomeCare Corporation (ADUS) is the lower-risk stock at 0.41β versus Enhabit, Inc.'s 0.56β — meaning EHAB is approximately 39% more volatile than ADUS relative to the S&P 500. On balance sheet safety, Addus HomeCare Corporation (ADUS) carries a lower debt/equity ratio of 19% versus 103% for Enhabit, Inc. — giving it more financial flexibility in a downturn.

05

Which has better profit margins — ADUS or EHAB?

Addus HomeCare Corporation (ADUS) is the more profitable company, earning 6.7% net margin versus -15.1% for Enhabit, Inc. — meaning it keeps 6.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9.7% versus -11.1% for EHAB. At the gross margin level — before operating expenses — EHAB leads at 48.7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is ADUS or EHAB more undervalued right now?

On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 15.0x forward P/E versus 22.5x for Enhabit, Inc. — 7.5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADUS: 28.2% to $132.75.

07

Which pays a better dividend — ADUS or EHAB?

None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is ADUS or EHAB better for a retirement portfolio?

For long-horizon retirement investors, Addus HomeCare Corporation (ADUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.41), +356.1% 10Y return). Both have compounded well over 10 years (ADUS: +356.1%, EHAB: -45.6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between ADUS and EHAB?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.

Stocks Like

ADUS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 5%
Run This Screen
📊
Stocks Like

EHAB

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 29%
Run This Screen
Custom Screen

Better Than Both

Find stocks that beat ADUS and EHAB on the metrics you choose

Revenue Growth>
%
(ADUS: 25.6% · EHAB: 3.9%)